[Evaluation of mouse brain-derived, inactivated Japanese encephalitis vaccine].
Japanese encephalitis (JE) is a serious encephalitis caused by JE virus. Approximately 20% of JE patients die and 50% patients recover with neuro-psychiatric sequelae. In Japan, the number of JE patients was over 1000 per year in 1960s; however, the number decreased dramatically and has been less than 10 since 1990. Ministry of Health, Labour and Welfare suspended the strong recommendation for vaccination with the mouse brain-derived JE vaccine, because of cases who developed acute disseminated encephalomyelitis (ADEM) after vaccination with JE vaccine. However, it has not been fully confirmed on scientific bases that ADEM was caused by mouse brain-derived JE vaccine. Tissue culture derived-JE vaccine is under development. It is expected that this new vaccine will come to the market soon and that the recommendation of universal vaccination with JE vaccine will be implemented at the earliest occasion.
Kurane
Ichiro
I
Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan. kurane@nih.go.jp
D000818:Animals; D001921:Brain / Q000821:virology; D004664:Encephalitis Virus, Japanese; D004673:Encephalomyelitis, Acute Disseminated / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007564:Japan; D022321:Japanese Encephalitis Vaccines / Q000009:adverse effects; D051379:Mice; D014611:Vaccination / Q000331:legislation & jurisprudence; D015164:Vaccines, Inactivated / Q000009:adverse effects
D022321:Japanese Encephalitis Vaccines; D015164:Vaccines, Inactivated